Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2011
Role of checkpoint kinase 1 (Chk1) in the mechanisms of resistance to histone deacetylase inhibitorsJu-Hee Lee, Megan L Choy, Lang Ngo, et al.Novartis Foundation Symposium|June 3, 2004
Histone deacetylase inhibitors: development as cancer therapyPaul A Marks, Victoria M Richon, Wm Kevin Kelly, et al.Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repairJ-H Lee, M L Choy, L Ngo, et al.Anticancer Research|August 10, 2002
Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumorsLeonard A Cohen, Paul A Marks, Richard A Rifkind, et al.Plos One|December 6, 2011
SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's diseaseMichal Mielcarek, Caroline L Benn, Sophie A Franklin, et al.Investigative Ophthalmology & Visual Science|April 24, 2009
Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implicationsVassiliki Poulaki, Constantine S Mitsiades, Vassiliki Kotoula, et al.Proceedings of the National Academy of Sciences of the United States of America|August 22, 2002
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxinLisa M Butler, Xianbo Zhou, Wei-Sheng Xu, et al.Proceedings of the National Academy of Sciences of the United States of America|September 16, 2015
Creation of a histone deacetylase 6 inhibitor and its biological effects [corrected]Ju-Hee Lee, Yuanshan Yao, Adaickapillai Mahendran, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2004
Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acidChristopher M Reilly, Nilamadhab Mishra, Julie M Miller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Novel histone deacetylase inhibitors in the treatment of thyroid cancerConstantine S Mitsiades, Vassiliki Poulaki, Ciaran McMullan, et al.Pageof 7